The Neurology Minute® podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology® journals, Neurology Today®, Continuum®, and more.
Artificial intelligence may assist neurological diagnosis, including in emergency care, but remains a clinical tool rather than a replacement for history-taking or neurological examination, with training relevant to senior neurologists and consultants as well as residents.
Accessible brain health education combines trusted expert information, practical resources and personal stories to help patients, families and communities understand complex subjects, share what they learn and identify useful next steps throughout life.
Early dexamethasone alongside antibiotics in pneumococcal meningitis aims to limit the inflammatory response to infection and bacterial killing, with benefits for hearing and cognition dependent on giving treatment before or soon after the first antibiotic dose.
Prospective Dutch cohort data associate early, complete dexamethasone treatment with better outcomes in Listeria meningitis, challenging older advice to stop steroids once Listeria is identified while leaving important uncertainty because the evidence is observational rather than randomised.
Newer myasthenia gravis treatments including FCR inhibitors, complement inhibitors and CD19 plus B-cell depletion therapy show comparable efficacy and similar adverse-effect findings in a Bayesian meta-analysis, but differences between trial populations limit confident treatment ranking.
Adjunctive dexamethasone in herpes simplex virus encephalitis did not improve verbal memory or neurological outcomes in the main DEX-ENCEPH analysis, although an exploratory timing analysis suggested possible benefit from very early treatment without evidence of impaired viral clearance.
US Medicare data from 2013 to 2023 show inflation-adjusted hospital resource requirements for inpatient neurological care rising substantially faster than reimbursement, creating a widening financial gap with potential implications for the sustainability of specialist neurological services.
Progressive bilateral visual loss with spastic paraparesis in a chronically immunosuppressed patient may indicate Peguivirus-associated encephalomyelitis. Cerebrospinal fluid detection alone is insufficient; the clinical phenotype, tract-focused magnetic resonance imaging pattern, sample quality and tissue evidence should be assessed together.
Rapidly progressive encephalopathy after influenza A raises concern for acute necrotising encephalopathy, especially with bilateral thalamic or brainstem magnetic resonance imaging lesions. The discussion covers inflammatory treatment, targeted RANBP2 testing, recurrence risk and prevention planning.
Blood biomarkers may make assessment of Alzheimer’s disease-related changes more accessible and cost-effective in symptomatic patients. Current diagnostic use should remain separate from the future possibility of identifying people at risk before symptoms develop.
.svg)